cell-based assays
PerkinElmer Acquiring Nexcelom Bioscience for $260M
Nexcelom provides tools for cell counting and analysis, including automated cell counting instruments, image cytometry workstations, and assays.
Metrion Biosciences Closes £2.7M in Equity Financing
Gresham House Ventures led the investment in Cambridge, UK-based Metrion Biosciences, which specializes in ion channel contract research and drug discovery.
Berkeley Lights Q4 Revenues Rise 31 Percent
The cell analysis firm beat the consensus top line Wall Street estimates for Q4 and full-year 2020, but missed on the bottom line for the year.
Berkeley Lights Q3 Revenues Grow 16 Percent
In its first complete quarter as a publicly traded company, Berkeley Lights reported $18.2 million in total revenues, including $4.1 million in service revenues.
Epigenomic Study of Brain Development Uncovers Cell Type-Specific Regulatory Programs
Researchers linked chromatin interactions, super-interactive promoters, and other regulatory features to specific cell types in the developing brain cortex.